A clinical guide to the management of Graves' disease with radioactive iodine.

Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
C Levetan, L Wartofsky

Abstract

More than 50 years have passed since radioactive iodine (RAI) was initially demonstrated as a therapeutic modality for the treatment of Graves' Disease. Today, more than a million patients have been treated with RAI. RAI is considered safe and highly effective. Its side-effect profile, ease of administration, and relative cost make RAI the treatment of choice for Graves' Disease of thyroidologists in this country. Questions continue to be raised as to which patients will benefit most from RAI therapy. Marked differences still exist between the practice preferences of thyroidologists as to whom, when, and how to treat with RAI. Factors that influence patient selection for RAI include age, the presence of pre-existing ophthalmopathy, lifestyle, history of previous treatment failure, and goiter size. Treatment goals, dosimetry, use of thionamides prior to therapy, safety recommendations following therapy, and prophylactic therapy with glucocorticoids for patients with ophthalmopathy highlight are some of the controversial issues facing the endocrinologist treating Graves' Disease with RAI. This symposium article reviews the current management of Graves' Disease with RAI.

References

Jan 23, 1975·The New England Journal of Medicine·A M SafaA Rodriguez-Antunez
Sep 10, 1977·British Medical Journal·J S StaffurthS N Fui
Jun 25, 1992·The New England Journal of Medicine·L TallstedtA Taube
Oct 29, 1992·The New England Journal of Medicine·A J Vora, J S Lilleyman
Jan 1, 1991·Thyroid : Official Journal of the American Thyroid Association·L WartofskyM Izumi
Jun 1, 1990·The Journal of Clinical Endocrinology and Metabolism·B SolomonL Wartofsky
Sep 1, 1991·Clinical Endocrinology·J J Farrar, A D Toft
May 26, 1990·Lancet·B ShineA P Weetman
Jun 1, 1991·The Journal of Clinical Endocrinology and Metabolism·G K HuberT F Davies
Feb 1, 1990·Journal of Endocrinological Investigation·L J DeGrootM McCormick
May 1, 1985·Clinics in Endocrinology and Metabolism·S Ratanachaiyavong, A M McGregor
May 1, 1985·The Journal of Clinical Endocrinology and Metabolism·J I Hamburger
Jul 1, 1989·The American Journal of Medicine·V Sridama, L J DeGroot
Jan 1, 1985·Acta Medica Scandinavica·O EshøjH Bliddal
Jan 1, 1985·Endocrine Reviews·K D Burman, J R Baker
Dec 1, 1986·Annals of Internal Medicine·G D Graham, K D Burman
Nov 26, 1973·JAMA : the Journal of the American Medical Association·L Wartofsky
May 24, 1980·Lancet·A M McGregorP J Dewar
Aug 1, 1983·The American Journal of Medicine·M T McDermottF D Hofeldt
Aug 11, 1984·British Medical Journal·P Kendall-TaylorW M Ross
Jan 1, 1984·European Journal of Nuclear Medicine·J M ConnellW D Alexander
Aug 1, 1983·The Journal of Clinical Endocrinology and Metabolism·D S RossE C Ridgway
Jan 1, 1993·Thyroid : Official Journal of the American Thyroid Association·L Wartofsky
Aug 1, 1993·The Quarterly Journal of Medicine·M A BaxterJ A Franklyn
Apr 1, 1958·A.M.A. Archives of Ophthalmology·J W BETTMANP CHAO
Nov 26, 1960·British Medical Journal·E E POCHIN
Jan 16, 1960·British Medical Journal·J CROOKSE MACDONALD

❮ Previous
Next ❯

Citations

Apr 16, 1998·Endocrinology and Metabolism Clinics of North America·D S Cooper
Apr 9, 1998·Baillière's Clinical Endocrinology and Metabolism·E G Levy
Apr 1, 1997·Thyroid : Official Journal of the American Thyroid Association·L Wartofsky
Jan 1, 1991·Clinical Endocrinology·J A FranklynM C Sheppard
Feb 7, 2006·The Journal of Surgical Research·Chris M Schüssler-FiorenzaHerbert Chen
Mar 16, 2000·Thyroid : Official Journal of the American Thyroid Association·K J Lucas
Jul 15, 2006·Thyroid : Official Journal of the American Thyroid Association·N N PatelM P J Vanderpump
Sep 15, 1996·Hospital Practice·L Wartofsky

❮ Previous
Next ❯

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
G Medeiros-Neto
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
D S Ross
© 2022 Meta ULC. All rights reserved